Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations

American Journal of Reproductive Immunology

Volumn 54, Issue 6, 2005, Pages 352-357

  Feinberg, Bruce B ^a,c   Jack, Richard M ^a,b   Mok, Samuel C ^a   Anderson, Deborah J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Complement; Immune complex; Inflammation; Preeclampsia; Pregnancy

Indexed keywords

ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ERYTHROCYTES; FEMALE; HUMANS; PEPTIDE HYDROLASES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, COMPLEMENT 3B;

EID: 28644451288     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00318.x     Document Type: Article

References (24)

1. Schifferli JA, Ng YC, Estreicher J, Walport MJ: The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol 1988; 140:899-904.
2. Wilson JG, Murphy BE, Wong WW, Klickstein LB, Weis JH, Fearon DT: Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986; 164:50-59.
3. Wilson JG, Wong WW, Schur PH, Fearon DT: Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosis. N Eng J Med 1982; 307:981-986
4. Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ: Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985; 59:547-554.
5. Raju KR, Sivasankar B, Anand V, Luthra K, Tiwari SC, Dinda AK, Das N, Srivastava LM: Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies. Asian Pac J Allergy Immunol 2001; 19:23-27.
6. Redman CWG, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
7. Diagnosis and management of preeclampsia and eclampsia ACOG Practice Bulletin, 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99:159-167.
8. Changelian PS, Jack RM, Collins LA, Collins DT: PMA induces ligand independent internalization of CR1 on human neutrophils. J Immunol 1985; 134:1851-1858.
9. Barbosa JE, Harrison RA, Barker PJ, Lachmann PJ: An anti-peptide antibody that recognizes a neoantigen in the CR1 stump remaining on erythrocytes after proteolysis. Clin Exp Immunol 1992; 87:144-149.
10. Cornillet P, Philbert F, Kazatchkine MD, Cohen JHM: Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 1991; 136:193-197.
11. Isolation of DNA from mammalian cells. In Molecular Cloning: a Laboratory Manual, 2nd edn, Section 9.16., J Sambrook, EF Fritsch, T Maniatis (eds). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989, pp 148-153.
12. Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A: Complement, neutrophil and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 1992; 79:19-26.
13. Tosi MF, Zakem H, Berger M: Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990; 86:300-308.
14. Fearon DT: Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med 1980; 152:20-30.
15. Medicus RG, Melamed J, Arnaout MA: Role of human factor I and C3b receptor and the cleavage of surface-bound C3bi molecules. Eur J Immunol 1983; 13:465-470.
16. Bacle FR, Haeffner-Cavaillon N, Laude M, Couturier C, Kazatchkine MD: Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes. J Immunol 1990; 144:147-152.
17. Daha MR, Bloem AC, Ballieux RE: Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. J Immunol 1984; 132:1197-1201.
18. Hourcade D, Miesner DR, Bee C, Zeldes W, Atkinson JP: Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. J Biol Chem 1990; 265:974-980.
19. Wong WW, Farrell SA: Proposed structure of the F′ allotype of human CR1. Loss of a C3b binding site may be associated with altered function. J Immunol 1991; 146:656-662.
20. Hebert LA, Cosio FG, Birmingham DJ, Mahan JD, Sharma HM, Smead WL, Goel R: Experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int 1991; 39:44-56.
21. Guo F, Qian SZ: Preliminary study on the immune function of red cells in patients with pregnancy-induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1989; 24:215-216, 252.
22. Tang YZ: Preliminary study of immune function of erythrocytes in normal and high-risk pregnant and post-partum women. Zhonghua Fu Chan Ke Za Zhi 1990; 25:102-104, 125.
23. Allen T: The role of the erythrocyte C3b (CR1) receptor in the pathogenesis of pre-eclampsia Transfus Med 1991; 1(Suppl. 2):62 (abstract).
24. Imrie HJ, McGonigle TP, Liu DT, Jones DR: Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy. J Reprod Immunol 1996; 31:221-227.